Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias.
Spinocerebellar Ataxia, SCA, CACNA1A, PRKCG, AFG3L2, ITPR1, STUB1, SPTBN2, KCNC3, onset
Journal
American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475
Informations de publication
Date de publication:
06 07 2023
06 07 2023
Historique:
received:
26
03
2023
revised:
18
05
2023
accepted:
19
05
2023
medline:
10
7
2023
pubmed:
11
6
2023
entrez:
10
6
2023
Statut:
ppublish
Résumé
Although the best-known spinocerebellar ataxias (SCAs) are triplet repeat diseases, many SCAs are not caused by repeat expansions. The rarity of individual non-expansion SCAs, however, has made it difficult to discern genotype-phenotype correlations. We therefore screened individuals who had been found to bear variants in a non-expansion SCA-associated gene through genetic testing, and after we eliminated genetic groups that had fewer than 30 subjects, there were 756 subjects bearing single-nucleotide variants or deletions in one of seven genes: CACNA1A (239 subjects), PRKCG (175), AFG3L2 (101), ITPR1 (91), STUB1 (77), SPTBN2 (39), or KCNC3 (34). We compared age at onset, disease features, and progression by gene and variant. There were no features that reliably distinguished one of these SCAs from another, and several genes-CACNA1A, ITPR1, SPTBN2, and KCNC3-were associated with both adult-onset and infantile-onset forms of disease, which also differed in presentation. Nevertheless, progression was overall very slow, and STUB1-associated disease was the fastest. Several variants in CACNA1A showed particularly wide ranges in age at onset: one variant produced anything from infantile developmental delay to ataxia onset at 64 years of age within the same family. For CACNA1A, ITPR1, and SPTBN2, the type of variant and charge change on the protein greatly affected the phenotype, defying pathogenicity prediction algorithms. Even with next-generation sequencing, accurate diagnosis requires dialogue between the clinician and the geneticist.
Identifiants
pubmed: 37301203
pii: S0002-9297(23)00166-0
doi: 10.1016/j.ajhg.2023.05.009
pmc: PMC10357418
pii:
doi:
Substances chimiques
AFG3L2 protein, human
EC 3.4.24.-
ATPases Associated with Diverse Cellular Activities
EC 3.6.4.-
ATP-Dependent Proteases
EC 3.4.21.-
STUB1 protein, human
EC 2.3.2.27
Ubiquitin-Protein Ligases
EC 2.3.2.27
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1098-1109Subventions
Organisme : Medical Research Council
ID : MR/S01165X/1
Pays : United Kingdom
Informations de copyright
Copyright © 2023 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interest.
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Brain. 2017 Jun 1;140(6):1579-1594
pubmed: 28444220
Neuropharmacology. 1997 Mar;36(3):405-9
pubmed: 9175621
Brain. 2009 Oct;132(Pt 10):2688-98
pubmed: 19696032
Nat Rev Dis Primers. 2019 Apr 11;5(1):24
pubmed: 30975995
Clin Genet. 2022 Oct;102(4):288-295
pubmed: 35722745
Cell Rep. 2019 Jan 29;26(5):1189-1202.e6
pubmed: 30699348
Cerebellum. 2013 Jun;12(3):418-28
pubmed: 23090211
Ann Neurol. 2022 Jul;92(1):122-137
pubmed: 35411967
Hum Mutat. 2010 Feb;31(2):191-6
pubmed: 19953606
Genet Med. 2022 Jan;24(1):29-40
pubmed: 34906452
Lancet Neurol. 2010 Sep;9(9):885-94
pubmed: 20723845
Neuroepidemiology. 2014;42(3):174-83
pubmed: 24603320
Eur J Neurol. 2020 Nov;27(11):2267-2276
pubmed: 32558018
Neurology. 2006 Jun 13;66(11):1717-20
pubmed: 16769946
Trends Neurosci. 1998 Apr;21(4):148-54
pubmed: 9554724
Cerebellum. 2019 Aug;18(4):817-822
pubmed: 31111429
Eur J Hum Genet. 2018 Nov;26(11):1623-1634
pubmed: 29925855
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Lancet Neurol. 2004 May;3(5):291-304
pubmed: 15099544
Hum Mol Genet. 1997 Oct;6(11):1973-8
pubmed: 9302278
Genet Med. 2023 Feb;25(2):100327
pubmed: 36422518
Brain. 2017 Nov 1;140(11):2860-2878
pubmed: 29053796
Hum Genet. 2019 Sep;138(8-9):881-898
pubmed: 30242502
Ann Clin Transl Neurol. 2021 Apr;8(4):956-963
pubmed: 33756041
Eur J Neurosci. 2007 Nov;26(10):2950-61
pubmed: 18001290
Proc Natl Acad Sci U S A. 2021 Oct 5;118(40):
pubmed: 34580197
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W252-8
pubmed: 24782522
PLoS Genet. 2020 Oct 19;16(10):e1009118
pubmed: 33075064
FASEB J. 2019 Dec;33(12):13852-13865
pubmed: 31648575
Genet Med. 2020 Nov;22(11):1851-1862
pubmed: 32713943
Neurodegener Dis. 2009;6(1-2):16-22
pubmed: 19066432
J Child Neurol. 2020 Feb;35(2):106-110
pubmed: 31617442
Mol Cell Oncol. 2017 Sep 28;4(6):e1372867
pubmed: 29209655